Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 105 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Katsiki, Niki [Clear All Filters]
(2016).
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Contrast-Induced Nephropathy: An "All or None" Phenomenon?.
Angiology. 66(6), 508-13.
(2015). Editorial: effect of statins on rates of long-term cardiovascular events and restenosis following carotid endarterectomy..
Curr Vasc Pharmacol. 13(2), 223-5.
(2015). Editorial: microRNAs: Potential Targets for the Treatment of Cardiovascular Disease..
Curr Vasc Pharmacol. 13(3), 366-7.
(2015). Health benefits of the Mediterranean Diet: an update of research over the last 5 years..
Angiology. 66(4), 304-18.
(2015). High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus..
J Diabetes Complications. 29(1), 142-5.
(2015). Hyperuricemia as a risk factor for cardiovascular disease..
Expert Rev Cardiovasc Ther. 13(1), 19-20.
(2015). Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome..
World J Gastroenterol. 21(25), 7860-8.
(2015). Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention..
Curr Med Res Opin. 31(2), 191-5.
(2015). Statin therapy and cardiovascular outcomes after coronary revascularization in the elderly..
Atherosclerosis. 238(2), 182-4.
(2015). Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?.
Expert Opin Pharmacother. 16(10), 1449-61.
(2015). The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!.
Curr Med Res Opin. 30(9), 1701-5.
(2014). Achieving lipid targets in primary care settings..
Curr Med Res Opin. 30(10), 1971-4.
(2014).
(2014). Are statins 'IDEAL' for non-alcoholic fatty liver disease?.
Curr Med Res Opin. 30(2), 229-31.
(2014). Beneficial effects of high atorvastatin dose reloading prior to percutaneous coronary intervention..
Curr Med Res Opin. 30(1), 55.
(2014). Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview..
Curr Vasc Pharmacol. 12(4), 627-41.
(2014). Editorial: (New drug (LCZ696) for the treatment of heart failure with reduced ejection fraction after 10 years. Can one study change the guidelines?)..
Curr Vasc Pharmacol. 12(6), 867-9.
(2014). Editorial: (Persistent elevation of blood pressure in children and adolescents is associated with arterial hypertension and premature atherosclerosis in adults. Is it possible to reverse this?)..
Curr Vasc Pharmacol. 12(6), 870-2.
(2014). Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report..
Curr Vasc Pharmacol. 12(3), 505-11.
(2014). Effect of Statins on rates of Long-Term Cardiovascular Events and Restenosis Following Carotid Endarterectomy..
Curr Vasc Pharmacol.
(2014). Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness..
J Am Soc Hypertens. 8(2), 74-82.
(2014). Gene polymorphisms and thyroid function in patients with heart failure..
Endocrine. 45(1), 46-54.
(2014). Metabolic syndrome and non-cardiac vascular diseases: an update from human studies..
Curr Pharm Des. 20(31), 4944-52.
(2014).